Intelligence / Services / Auditor Changes / Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc.
28 Sept 2026: Changed auditor (SEC 8-K) · Grassi & Co., CPAs. Recorded in the SEC EDGAR full-text search.
- Filed
- 28 Sept 2026
- Ticker
- HEPA
- Sector
- Pharma and biotech
- Sic
- 2834
- Items
- 4.01, 9.01
- Location
- Red Bank, NJ
- State
- New Jersey
- Country
- United States
- SEC CIK
- 1583771
- Reference
- 0001493152-26-044432
- Former
- Grassi & Co., CPAs
- Event
- Auditor dismissed
A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.
- Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
- 22 added in the 30 days to 19 Nov 2026.
Find the decision makers at Hepion Pharmaceuticals, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.
Across AOS Research
Other records for Hepion Pharmaceuticals, Inc. in our registers.
More in Auditor dismissed
Auditor Changes
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.